INVESTOR PROFILE

Xora Innovation

Xora Innovation

Xora Innovation

Singapore

Xora Innovation is a subsidiary of the Singapore sovereign investment fund, Temasek. It was established as an early-stage deeptech investment platform that identifies startups connected with the Singapore science and technology ecosystem (although the startup can be based anywhere in the world). Xora plans to invest as a lead or co-lead in seed or Series A rounds, with later-stage investments being handled through Temasek. As of July 2021, Xora has invested in two companies based in Singapore: Allozymes, which provides enzyme engineering services, and Nuevocor, which is developing gene therapy for certain heart diseases.

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Chengwei Capital

Investor

Chengwei Capital

China

Pere Valles

Investor

Pere Valles

Spain

REDangels

Investor

REDangels

Portugal

RECOMMENDED

Chengwei Capital

Investors

Chengwei Capital

China

Pere Valles

Investors

Pere Valles

Spain

REDangels

Investors

REDangels

Portugal

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.